Navigation Links
CareFusion Reports First Quarter Fiscal 2011 Results; Reaffirms Fiscal 2011 Financial Guidance
Date:11/2/2010

g nonrecurring items, adjusted operating expenses in the first quarter totaled $318 million, or 35 percent of total revenue. Adjusted SG&A expenses were $278 million and R&D investments totaled $40 million.

The company reported net income in the first quarter of $38 million, or $0.17 per diluted share. Adjusted net income was $67 million, or $0.30 per diluted share, and the adjusted tax rate was 31.7 percent for the first quarter.

Summary of Segment ResultsCritical Care Technologies

Revenue for the Critical Care Technologies segment totaled $617 million, and was flat on a reported basis and increased 1 percent on a constant currency basis compared to the prior year period. Segment revenues in the quarter were driven by an increase in the company's Infusion product sales, which included core Infusion growth and a contribution from the company's May 2010 acquisition of Medegen. The increase in Infusion sales was primarily offset by decreases in the company's Respiratory product line revenues. Respiratory sales were negatively impacted by a weak post H1N1 environment that drove lower capital and consumable sales both in the U.S. and internationally as declines in hospital admissions and a lighter flu season drove softer demand and utilization than expected.

Segment profit decreased 30 percent to $71 million. Adjusted segment profit decreased 11 percent to $100 million, primarily due to strong Infusion and Respiratory results in the first quarter of fiscal 2010, which had benefited from an increase in Infusion revenues and earnings following the release of the ship hold on our Alaris® System in July 2009 and increased Respiratory revenues and earnings related to H1N1.

Medical Technologies and Services

Revenue for the Medical Technologies and Services segment decreased 5 percent to $291 million, or a 3 percent decrease on a constant currency basis, driven by decreased sales in the company's
'/>"/>

SOURCE CareFusion Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. CareFusion Selects Palomar Pomerado Health as Development Partner for Patient Safety Technologies
2. CareFusion Will Host an Earnings Conference Call on Nov. 2 to Discuss the Results for the First Quarter Fiscal 2011
3. CareFusion Recall of Alaris PC Units Model 8015 Classified as Class I Recall
4. CareFusion Expands Skin Antisepsis Portfolio
5. CareFusion and Blue Cross and Blue Shield of Illinois Create Illinois Hospital Quality Initiative to Help Eliminate Health Care-Associated Infections
6. CareFusion Announces National Launch of Spinal Fracture Device
7. CareFusion Will Host an Earnings Conference Call on Aug. 10 to Discuss the Results for the Fourth Quarter and Fiscal 2010
8. CareFusion Launches First Automatic Oxygen Controller to Improve Care for Newborns Needing Mechanical Ventilation
9. CareFusion Completes Medegen Acquisition
10. CareFusion Announces Agreement With Banner Health to Upgrade and Extend Pyxis Medication Solutions
11. CareFusion, Cerner to Integrate Technologies for Improved Hospital Safety, Efficiency
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... and PARIS , July 28, 2015 ... Sanofi have entered into a new global collaboration to ... the emerging field of immuno-oncology. As part of the ... cell death protein 1 (PD-1) inhibitor currently in Phase ... 2016 with new therapeutic candidates based on ongoing, innovative ...
(Date:7/27/2015)... United Kingdom , July 27, 2015 /PRNewswire/ ... a leading specialty biopharmaceutical company, announced today that ... which it will sell its global contrast media ... NYSE Euronext) in a transaction valued at approximately ... divest its CMDS business is consistent with the ...
(Date:7/27/2015)... and PITTSBURGH , July 27, ... that it will hold its extraordinary general meeting of shareholders ... (NYSE: PRGO ; TASE) at the Okura Hotel Amsterdam ... Time (CET). Among other agenda items at ... on the approval, under article 2:107a of the Dutch Civil ...
Breaking Medicine Technology:Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 2Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 3Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 4Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 5Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 6Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 7Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 8Mallinckrodt Enters Agreement To Sell Its Contrast Media And Delivery Systems Imaging Business To Guerbet For $270 Million 2Mallinckrodt Enters Agreement To Sell Its Contrast Media And Delivery Systems Imaging Business To Guerbet For $270 Million 3Mallinckrodt Enters Agreement To Sell Its Contrast Media And Delivery Systems Imaging Business To Guerbet For $270 Million 4Mallinckrodt Enters Agreement To Sell Its Contrast Media And Delivery Systems Imaging Business To Guerbet For $270 Million 5Mallinckrodt Enters Agreement To Sell Its Contrast Media And Delivery Systems Imaging Business To Guerbet For $270 Million 6Mallinckrodt Enters Agreement To Sell Its Contrast Media And Delivery Systems Imaging Business To Guerbet For $270 Million 7Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 2Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 3Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 4Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 5Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 6Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 7Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 8Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 9Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 10
... 2011 Double Eagle Holdings, Ltd. (OTCQB: ... www.fusescience.com ), announced today that it has entered into ... Inc. (PDT Inc.), a California-based pharmaceutical consulting firm. Double ... Inc., the developer of new, patent-pending technologies poised to ...
... the worldwide leader in 3D Molecular Breast Imaging (MBI), ... the Naviscan Board of Directors. Dr. Cheng ... in the medical device industry.  He served as the ... Inc.  After acquisition by Ethicon, Inc., a Johnson & ...
Cached Medicine Technology:Double Eagle Holdings Enters Into Supply Agreement with Platform Delivery Technologies Inc. 2Double Eagle Holdings Enters Into Supply Agreement with Platform Delivery Technologies Inc. 3Naviscan Further Strengthens its Board of Directors With the Addition of Dr. Andre Cheng 2
(Date:7/28/2015)... ... 2015 , ... North American Seminars will present seventeen ... . These seventeen courses are pre-approved for CME credit for Physical therapists, ... the Older Adult , August 22, 2015 - August 23, 2015 presented ...
(Date:7/28/2015)... Orange, NJ (PRWEB) , ... July 28, 2015 , ... ... on the sidelines – or in your easy chair? Luckily, there are plenty of ... Kadimcherla, MD , an orthopedic spine surgeon at Atlantic Spine Center . ...
(Date:7/28/2015)... ... ... President of the Veterans Fund of the United States, managing the United Veteran Beacon House ... a campaign to help homeless Veterans by giving them “A hand up – not a ... the UVBH assists and supports Vets through the Veterans Fund of the United States ...
(Date:7/27/2015)... ... ... Dr. Robert G. Schwartz , principal of Greenville, SC-based Piedmont Physical Medicine ... in order to offer his patients a new system of care utilizing laser therapy ... Peripheral neuropathy is a disease caused by damage to the peripheral nerves, and typically ...
(Date:7/27/2015)... ... July 28, 2015 , ... Combination Product GMP Compliance:, Understanding FDA’s ... EDT, http:// http://www.fdanews.com/comboproductgmpcompliance , Manufacturing a drug or device is ... things can get messy in a hurry. In a 46-page draft guidance released in ...
Breaking Medicine News(10 mins):Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 2Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 3Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 4Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 5Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 6Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 7Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 8Health News:Safe Cardio for Back Pain Sufferers 2Health News:Safe Cardio for Back Pain Sufferers 3Health News:Veterans Fund of the United States Launches “Adopt A Homeless Veteran” Campaign 2Health News:Veterans Fund of the United States Launches “Adopt A Homeless Veteran” Campaign 3Health News:Piedmont Physical Medicine & Rehabilitation, P.A. Partners with Realief® Neuropathy Centers to Offer Peripheral Neuropathy Laser Treatment 2Health News:FDAnews Announces — Combination Product GMP Compliance: Understanding FDA’s New Streamline Approach Webinar, Aug. 19, 2015 2Health News:FDAnews Announces — Combination Product GMP Compliance: Understanding FDA’s New Streamline Approach Webinar, Aug. 19, 2015 3Health News:FDAnews Announces — Combination Product GMP Compliance: Understanding FDA’s New Streamline Approach Webinar, Aug. 19, 2015 4
... progression, mouse study suggests , , MONDAY, April 14 (HealthDay ... cholesterol and one is an anti-inflammatory -- may be ... presented at the American Association for Cancer Research annual ... and the statin Lipitor, when used together or alone, ...
... Kimmel Cancer Center at Thomas Jefferson University in ... blood pressure medications might help prevent the spread ... laboratory that one type of pressure-lowering drug called ... growth and causes cell death. , In earlier ...
... Real-Time In Vivo Data via Quantitative ... ... Inc., a leader,in fluorescence in vivo imaging, today announced the commercial ... is based on VisEn,s,proprietary Fluorescence Molecular Tomography (FMT(TM)) technology,platform, and combined ...
... 14 HealthFusion, a,national clearinghouse for ... center operation customer satisfaction excellence under ... Center Program(SM). This distinction,acknowledges a strong ... to provide "An Outstanding Customer Service ...
... As the first of the,nation,s 78 million baby boomers ... health care work force that is too small and ... new report from the Institute of,Medicine. The report calls ... providers -- not just specialists -- in the basics ...
... Denise Kehoe has joined,medication therapy management (MTM) company ... new role, she will manage and oversee the,expansion ... the country., Kehoe brings more than 15 ... PharmMD. She recently served as national strategic,executive of ...
Cached Medicine News:Health News:Celebrex Plus Lipitor Could Fight Prostate Cancer 2Health News:Celebrex Plus Lipitor Could Fight Prostate Cancer 3Health News:Blood pressure drugs halt pancreatic cancer cell growth, Jefferson researchers find 2Health News:VisEn Medical Launches FMT(TM) 2500 - Next-Generation Fluorescence Imaging System 2Health News:J.D. Power and Associates Reports: HealthFusion Recognized for Providing an Outstanding Customer Service Experience 2Health News:J.D. Power and Associates Reports: HealthFusion Recognized for Providing an Outstanding Customer Service Experience 3Health News:Health Care Work Force Too Small, Unprepared for Aging Baby Boomers; Higher Pay, More Training, and Changes in Care Delivery Needed to Avert Crisis 2Health News:PharmMD Announces Denise Kehoe as Vice President of Business Development 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: